Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Integrity of Down Inhibitor Bundle at Patients Suffering of Neuropathic Pain (PhyDoNe)

This study has been completed.
Sponsor:
Collaborator:
Grünenthal GmbH
Information provided by (Responsible Party):
University Hospital, Clermont-Ferrand
ClinicalTrials.gov Identifier:
NCT01053845
First received: January 19, 2010
Last updated: July 4, 2014
Last verified: July 2014

January 19, 2010
July 4, 2014
April 2010
May 2011   (final data collection date for primary outcome measure)
Comparison of the amplitude of N2P2 waves between healthy volunteers and patients suffering of peripheral neuropathic pain. [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT01053845 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Study of Integrity of Down Inhibitor Bundle at Patients Suffering of Neuropathic Pain
Study of Integrity of Down Inhibitor Bundle at Patients Suffering of Neuropathic Pain

Several studies showed that activity of down inhibitor bundle is weakened in different painful pathologies as the fibromyalgy or the trigeminal nevralgy.

The purpose of the protocol is to study the working of down inhibitor bundle at patients suffering of neuropathic pain.

Prospective study with comparison groups

Interventional
Phase 1
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Diagnostic
  • Healthy Volunteers
  • Patients Suffering of Peripheral Neuropathic Pain
Other: Neuropathic pain
to study the working of down inhibitor bundle at patients suffering of neuropathic pain
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
20
May 2011
May 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • neuropathic patients group

    • Patient suffering of peripheral neuropathic pain
    • 18 years old women or men at least

Exclusion Criteria:

  • • Healthy volunteers

    • 18 years old women or men at least
Both
18 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
France
 
NCT01053845
CHU-0066, 2009-A00155-52
Not Provided
University Hospital, Clermont-Ferrand
University Hospital, Clermont-Ferrand
Grünenthal GmbH
Principal Investigator: Gisèle Pickering, Dr University Hospital, Clermont-Ferrand
University Hospital, Clermont-Ferrand
July 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP